Show simple item record

dc.contributor.authorHennessey, E.
dc.contributor.authorMooij, M.
dc.contributor.authorLegendre, C.
dc.contributor.authorReen, F.
dc.contributor.authorO'Callaghan, J.
dc.contributor.authorAdams, C.
dc.contributor.authorO'Gara, Fergal
dc.identifier.citationHennessey, E. and Mooij, M. and Legendre, C. and Reen, F. and O'Callaghan, J. and Adams, C. and O'Gara, F. 2013. Statins inhibit in vitro virulence phenotypes of Pseudomonas aeruginosa. Journal of Antibiotics. 66 (2): pp. 99-101.

Statins are a family of drugs that lower cholesterol levels by inhibiting 3-hydroxy-3-methylglutaryl-CoA-reductase, a rate-limiting enzyme in the human mevalonate pathway of which cholesterol is the biosynthetic end product.1 Statins also have a range of cholesterol-independent effects, including anti-inflammatory functions and antimicrobial activity. These pleiotropic effects are thought to account for the improved survival observed in statin-treated patients suffering from severe bacterial infections, such as sepsis and pneumonia. In order to identify the mechanism involved in the protective effects of statins against infection, research studies focused on the direct effect of statins on bacteria.

dc.publisherNature Publishing Group
dc.titleStatins inhibit in vitro virulence phenotypes of Pseudomonas aeruginosa
dc.typeJournal Article
dcterms.source.titleJournal of Antibiotics
curtin.accessStatusFulltext not available

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record